Branded, Generic Cos.' Reglan Win Stands In Appeals Court

Law360, New York (April 25, 2013, 8:13 PM EDT) -- An Iowa appeals court affirmed Wednesday that a user of generic Reglan can hold neither brand-name nor generic manufacturers of the digestion drug liable for her involuntary movement disorder, pointing to the U.S. Supreme Court's landmark Mensing ruling.

A three-judge panel found that a lower court was right to find that Theresa Huck's claims against Pliva Inc., the maker of the metoclopramide, fail under the Mensing decision, which held that state law failure-to-warn claims against generics makers are preempted by federal law, since the companies cannot...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.